Literature DB >> 23019612

Coagulation factor X activates innate immunity to human species C adenovirus.

Konstantin Doronin1, Justin W Flatt, Nelson C Di Paolo, Reeti Khare, Oleksandr Kalyuzhniy, Mauro Acchione, John P Sumida, Umeharu Ohto, Toshiyuki Shimizu, Sachiko Akashi-Takamura, Kensuke Miyake, James W MacDonald, Theo K Bammler, Richard P Beyer, Frederico M Farin, Phoebe L Stewart, Dmitry M Shayakhmetov.   

Abstract

Although coagulation factors play a role in host defense for "living fossils" such as horseshoe crabs, the role of the coagulation system in immunity in higher organisms remains unclear. We modeled the interface of human species C adenovirus (HAdv) interaction with coagulation factor X (FX) and introduced a mutation that abrogated formation of the HAdv-FX complex. In vivo genome-wide transcriptional profiling revealed that FX-binding-ablated virus failed to activate a distinct network of nuclear factor κB-dependent early-response genes that are activated by HAdv-FX complex downstream of TLR4/MyD88/TRIF/TRAF6 signaling. Our study implicates host factor "decoration" of the virus as a mechanism to trigger an innate immune sensor that responds to a misplacement of coagulation FX from the blood into intracellular macrophage compartments upon virus entry into the cell.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019612      PMCID: PMC4762479          DOI: 10.1126/science.1226625

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  21 in total

1.  Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases.

Authors:  C E Thomas; G Schiedner; S Kochanek; M G Castro; P R Löwenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

Review 3.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

4.  Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

Authors:  Y Zhang; N Chirmule; G P Gao; R Qian; M Croyle; B Joshi; J Tazelaar; J M Wilson
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

5.  Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

Authors:  Raul Alba; Angela C Bradshaw; Alan L Parker; David Bhella; Simon N Waddington; Stuart A Nicklin; Nico van Rooijen; Jerome Custers; Jaap Goudsmit; Dan H Barouch; John H McVey; Andrew H Baker
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

Review 6.  Adenovirus.

Authors:  Joseph P Lynch; Michael Fishbein; Marcela Echavarria
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

7.  Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons.

Authors:  Núria Morral; Wanda K O'Neal; Karen Rice; M Michelle Leland; Pedro A Piedra; Estuardo Aguilar-Córdova; K Dee Carey; Arthur L Beaudet; Claire Langston
Journal:  Hum Gene Ther       Date:  2002-01-01       Impact factor: 5.695

8.  Fatal disseminated adenoviral infection in a renal transplant patient.

Authors:  H Ardehali; K Volmar; C Roberts; M Forman; L C Becker
Journal:  Transplantation       Date:  2001-04-15       Impact factor: 4.939

9.  Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo.

Authors:  Nelson C Di Paolo; Edward A Miao; Yoichiro Iwakura; Kaja Murali-Krishna; Alan Aderem; Richard A Flavell; Thalia Papayannopoulou; Dmitry M Shayakhmetov
Journal:  Immunity       Date:  2009-07-02       Impact factor: 31.745

10.  Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm.

Authors:  Haitao Wen; Yu Lei; So-Young Eun; Jenny P-Y Ting
Journal:  J Exp Med       Date:  2010-11-22       Impact factor: 14.307

View more
  75 in total

Review 1.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

2.  FX and host defense evasion tactics by adenovirus.

Authors:  Andrew H Baker; Stuart A Nicklin; Dmitry M Shayakhmetov
Journal:  Mol Ther       Date:  2013-06       Impact factor: 11.454

Review 3.  Adenovirus sensing by the immune system.

Authors:  Svetlana Atasheva; Dmitry M Shayakhmetov
Journal:  Curr Opin Virol       Date:  2016-09-14       Impact factor: 7.090

Review 4.  The procoagulant envelope virus surface: contribution to enhanced infection.

Authors:  Edward L G Pryzdial; Michael R Sutherland; Wolfram Ruf
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

5.  1. Alternative splicing of viral receptors: A review of the diverse morphologies and physiologies of adenoviral receptors.

Authors:  Katherine J D A Excoffon; Jonathan R Bowers; Priyanka Sharma
Journal:  Recent Res Dev Virol       Date:  2014

6.  Adenovirus immunity: X marks the spot.

Authors:  Masataka Suzuki; Cliona M Rooney
Journal:  Mol Ther       Date:  2012-12       Impact factor: 11.454

Review 7.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

8.  Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.

Authors:  Sergey A Kaliberov; Lyudmila N Kaliberova; Zhi Hong Lu; Meredith A Preuss; Justin A Barnes; Cecil R Stockard; William E Grizzle; Jeffrey M Arbeit; David T Curiel
Journal:  Virology       Date:  2013-10-15       Impact factor: 3.616

9.  Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.

Authors:  Anne K Zaiss; Erin M Foley; Roger Lawrence; Lina S Schneider; Hamidreza Hoveida; Patrick Secrest; Arthur B Catapang; Yu Yamaguchi; Ramon Alemany; Dmitry M Shayakhmetov; Jeffrey D Esko; Harvey R Herschman
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

10.  Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.

Authors:  Zhili Xu; Qi Qiu; Jie Tian; Jeffrey S Smith; Gina M Conenello; Takashi Morita; Andrew P Byrnes
Journal:  Nat Med       Date:  2013-03-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.